Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?

ConclusionIf proven to have translational value, these observations would suggest thatCNS/bloodDER may be a key differentiator for siponimod over fingolimod for clinical efficacy in PMS.
Source: Neurology and Therapy - Category: Neurology Source Type: research